Here’s a link to Abigail Jones’ article on Music Against Myeloma, started to raise awareness for multiple myeloma http://bit.ly/2VKnb
Chris Abraham
Dear diary: I am finally an Internet celebrity, if a Gawker mention defines social media celebrity! http://bit.ly/qXUlW #gawker #valleywag
RT@FreshAirFund Are you a parent with questions about the FAF, what we do, and how it would work with your child? http://is.gd/1oVPw
RT@OLX_English Did you lose your pit bull near Fort Smith, Arkansas? Someone has it on OLX!: http://www.olx.com
Here’s why my account @chrisabraham was suspended for a few hours last night (freaked me out!) http://ping.fm/NlFHG
Puzzled by Boteach by Steven Eidman
I, Steven Eidman, was puzzled by Shmuley Boteach’s June 19 sounding of the battle cry against the Obama administration and its call for Israel to stop all building activity in the settlements. While I have no problem championing Israel’s interests and jeopardizing any dinner invitation that the president might be thinking of extending, I would first need more evidence that Israel was indeed threatened by U.S. demands. Successive Israeli governments, both left- and right-leaning, have agreed to dismantle the majority of the settlements and to surrender more than 90 percent of the land in the west bank to the Palestinian Authority, in the context of a negotiated peace treaty. Furthermore, Israel agreed to a settlement freeze in 2002, included in Phase I of the “roadmap for peace.”
http://ping.fm/N2P26
While the nuances of the word “freeze” may well need to be settled on, this can’t be the casus belli that Rabbi Boteach makes it out to be, as quiet diplomacy between our countries is already bringing us to an agreed-upon definition. I suspect the clear majority of the 78 percent of U.S. Jews who voted for Obama have no problem in supporting the president’s call for the freeze, especially as it was accompanied by a clear and forceful demand for an end to all terrorism and violence by the Palestinians. The presumption by Rabbi Boteach that only a “sunshine Jewish patriot” could support President Obama’s forceful attempt to make both sides adhere to their commitments in moving the peace process forward is unjustified, and doesn’t take into account the dramatic shifts that have already taken place — in Lebanon, in Iran, on the Syria-Iraq border — since the election of Obama. Other than in the Orthodox community, I expect most U.S. Jews to react to our president’s initiatives with cautious optimism. A rapprochement between the Palestinian Authority and Hamas, and the release of Gilad Shalit — both distinct possibilities — can change the entire landscape of the peace process. Let us press the White House to bring about these steppingstones to peace, rather than gird for war with it.
Steven Eidman, Englewood, NJ
http://ping.fm/AievI
http://ping.fm/N2P26
While the nuances of the word “freeze” may well need to be settled on, this can’t be the casus belli that Rabbi Boteach makes it out to be, as quiet diplomacy between our countries is already bringing us to an agreed-upon definition. I suspect the clear majority of the 78 percent of U.S. Jews who voted for Obama have no problem in supporting the president’s call for the freeze, especially as it was accompanied by a clear and forceful demand for an end to all terrorism and violence by the Palestinians. The presumption by Rabbi Boteach that only a “sunshine Jewish patriot” could support President Obama’s forceful attempt to make both sides adhere to their commitments in moving the peace process forward is unjustified, and doesn’t take into account the dramatic shifts that have already taken place — in Lebanon, in Iran, on the Syria-Iraq border — since the election of Obama. Other than in the Orthodox community, I expect most U.S. Jews to react to our president’s initiatives with cautious optimism. A rapprochement between the Palestinian Authority and Hamas, and the release of Gilad Shalit — both distinct possibilities — can change the entire landscape of the peace process. Let us press the White House to bring about these steppingstones to peace, rather than gird for war with it.
Steven Eidman, Englewood, NJ
http://ping.fm/AievI
Mobile post sent by chrisabraham using Utterli.
Puzzled by Boteach by Steven Eidman
I, Steven Eidman, was puzzled by Shmuley Boteach’s June 19 sounding of the battle cry against the Obama administration and its call for Israel to stop all building activity in the settlements. While I have no problem championing Israel’s interests and jeopardizing any dinner invitation that the president might be thinking of extending, I would first need more evidence that Israel was indeed threatened by U.S. demands. Successive Israeli governments, both left- and right-leaning, have agreed to dismantle the majority of the settlements and to surrender more than 90 percent of the land in the west bank to the Palestinian Authority, in the context of a negotiated peace treaty. Furthermore, Israel agreed to a settlement freeze in 2002, included in Phase I of the “roadmap for peace.”
While the nuances of the word “freeze” may well need to be settled on, this can’t be the casus belli that Rabbi Boteach makes it out to be, as quiet diplomacy between our countries is already bringing us to an agreed-upon definition. I suspect the clear majority of the 78 percent of U.S. Jews who voted for Obama have no problem in supporting the president’s call for the freeze, especially as it was accompanied by a clear and forceful demand for an end to all terrorism and violence by the Palestinians. The presumption by Rabbi Boteach that only a “sunshine Jewish patriot” could support President Obama’s forceful attempt to make both sides adhere to their commitments in moving the peace process forward is unjustified, and doesn’t take into account the dramatic shifts that have already taken place — in Lebanon, in Iran, on the Syria-Iraq border — since the election of Obama. Other than in the Orthodox community, I expect most U.S. Jews to react to our president’s initiatives with cautious optimism. A rapprochement between the Palestinian Authority and Hamas, and the release of Gilad Shalit — both distinct possibilities — can change the entire landscape of the peace process. Let us press the White House to bring about these steppingstones to peace, rather than gird for war with it.
Steven Eidman, Englewood, NJ
Are you afraid of losing all your Tweets if Twitter fails? Check out our corporate microblog: http://ahvoice.com on the Laconica platform.
Fuad El-Hibri Named Ernst & Young Entrepreneur o
Emergent BioSolutions Inc. EBS announced today that its chairman and chief executive officer, Mr. Fuad El-Hibri, is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award in the Greater Washington region. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. El-Hibri was selected as a finalist from nearly 100 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18 at the Ritz-Carlton, Tysons Corner in Virginia.
“It is an honor to be chosen as a finalist for the Ernst & Young Entrepreneur of the Year Award,” said Mr. Fuad El-Hibri. “I am proud of the entrepreneurial spirit, commitment, and collaboration that prevail at Emergent, which are key factors to our company’s success. This recognition represents the contributions of each and every member of the Emergent Team as we work together in pursuit of our company mission – to protect life.”
Mr. El-Hibri was also a finalist for the Greater Washington region in 2007. The Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.
About Ernst & Young’s Entrepreneur of the Year® Awards Program
Ernst & Young’s Entrepreneur of the Year® Award is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst & Young Entrepreneur of the Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.
In Greater Washington, sponsors include HSBC Bank, Pillsbury Law, Reznick Group, Lockton Companies and the Washington Business Journal.
“It is an honor to be chosen as a finalist for the Ernst & Young Entrepreneur of the Year Award,” said Mr. Fuad El-Hibri. “I am proud of the entrepreneurial spirit, commitment, and collaboration that prevail at Emergent, which are key factors to our company’s success. This recognition represents the contributions of each and every member of the Emergent Team as we work together in pursuit of our company mission – to protect life.”
Mr. El-Hibri was also a finalist for the Greater Washington region in 2007. The Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.
About Ernst & Young’s Entrepreneur of the Year® Awards Program
Ernst & Young’s Entrepreneur of the Year® Award is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst & Young Entrepreneur of the Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.
In Greater Washington, sponsors include HSBC Bank, Pillsbury Law, Reznick Group, Lockton Companies and the Washington Business Journal.
Mobile post sent by chrisabraham using Utterli.
Fuad El-Hibri Named Ernst & Young Entrepreneur of the Year Finalist
Emergent BioSolutions Inc. EBS announced today that its chairman and chief executive officer, Mr. Fuad El-Hibri, is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award in the Greater Washington region. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. El-Hibri was selected as a finalist from nearly 100 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18 at the Ritz-Carlton, Tysons Corner in Virginia.
“It is an honor to be chosen as a finalist for the Ernst & Young Entrepreneur of the Year Award,” said Mr. Fuad El-Hibri. “I am proud of the entrepreneurial spirit, commitment, and collaboration that prevail at Emergent, which are key factors to our company’s success. This recognition represents the contributions of each and every member of the Emergent Team as we work together in pursuit of our company mission – to protect life.”
Mr. El-Hibri was also a finalist for the Greater Washington region in 2007. The Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.
About Ernst & Young’s Entrepreneur of the Year® Awards Program
Ernst & Young’s Entrepreneur of the Year® Award is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst & Young Entrepreneur of the Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.
In Greater Washington, sponsors include HSBC Bank, Pillsbury Law, Reznick Group, Lockton Companies and the Washington Business Journal.
My buddy @dgelles interviewed Mark Zuckerberg for the FT, “What friends are for,” http://ping.fm/VSkBO
@AngelaCurrent I can’t share this ORM video for reasons of discretion but I have a deck for you here: http://ping.fm/MbnEQ
@dave_lo I can’t share this ORM video for reasons of discretion but I have a deck for you here: http://ping.fm/B1brI
RT@OLX_English Forget browsing used car lots. Check out OLX - there’s over 60,000 vehicles listed nationally on OLX http://www.olx.com
